Literature DB >> 12600938

Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor.

Karen Cichowski1, Sabrina Santiago, Melanie Jardim, Bryan W Johnson, Tyler Jacks.   

Abstract

Mutations in the NF1 tumor suppressor underlie the familial tumor predisposition syndrome neurofibromatosis type I. Although its encoded protein, neurofibromin, functions as a Ras-GTPase activating protein (GAP), nothing is known about how it is normally regulated or its precise role in controlling Ras signaling pathways. We show here that neurofibromin is dynamically regulated by the ubiquitin-proteasome pathway. Degradation is rapidly triggered in response to a variety of growth factors and requires sequences adjacent to the catalytic GAP-related domain of neurofibromin. However, whereas degradation is rapid, neurofibromin levels are re-elevated shortly after growth factor treatment. Accordingly, Nf1-deficient mouse embryonic fibroblasts (MEFs) exhibit an enhanced activation of Ras, prolonged Ras and ERK activities, and proliferate in response to subthreshold levels of growth factors. Thus, the dynamic proteasomal regulation of neurofibromin represents an important mechanism of controlling both the amplitude and duration of Ras-mediated signaling. Furthermore, this previously unrecognized Ras regulatory mechanism may be exploited therapeutically.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12600938      PMCID: PMC195996          DOI: 10.1101/gad.1054703

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  34 in total

1.  A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations.

Authors:  R M Cawthon; R Weiss; G F Xu; D Viskochil; M Culver; J Stevens; M Robertson; D Dunn; R Gesteland; P O'Connell
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

2.  Neurofibromas in NF1: Schwann cell origin and role of tumor environment.

Authors:  Yuan Zhu; Pritam Ghosh; Patrick Charnay; Dennis K Burns; Luis F Parada
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

3.  Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis.

Authors:  J E DeClue; A G Papageorge; J A Fletcher; S R Diehl; N Ratner; W C Vass; D R Lowy
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

4.  The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae.

Authors:  G F Xu; B Lin; K Tanaka; D Dunn; D Wood; R Gesteland; R White; R Weiss; F Tamanoi
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

5.  The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.

Authors:  G A Martin; D Viskochil; G Bollag; P C McCabe; W J Crosier; H Haubruck; L Conroy; R Clark; P O'Connell; R M Cawthon
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

6.  Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients.

Authors:  M R Wallace; D A Marchuk; L B Andersen; R Letcher; H M Odeh; A M Saulino; J W Fountain; A Brereton; J Nicholson; A L Mitchell
Journal:  Science       Date:  1990-07-13       Impact factor: 47.728

7.  Differential regulation of rasGAP and neurofibromatosis gene product activities.

Authors:  G Bollag; F McCormick
Journal:  Nature       Date:  1991-06-13       Impact factor: 49.962

8.  Regulation of Ras-GAP and the neurofibromatosis-1 gene product by eicosanoids.

Authors:  J W Han; F McCormick; I G Macara
Journal:  Science       Date:  1991-04-26       Impact factor: 47.728

9.  Genetic analysis of mammalian GAP expressed in yeast.

Authors:  R Ballester; T Michaeli; K Ferguson; H P Xu; F McCormick; M Wigler
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

10.  Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.

Authors:  H A Kim; T Rosenbaum; M A Marchionni; N Ratner; J E DeClue
Journal:  Oncogene       Date:  1995-07-20       Impact factor: 9.867

View more
  57 in total

Review 1.  Deconvoluting mTOR biology.

Authors:  Jason D Weber; David H Gutmann
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

Review 2.  Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Authors:  C Shilyansky; Y S Lee; A J Silva
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

Review 3.  Advances in sarcoma genomics and new therapeutic targets.

Authors:  Barry S Taylor; Jordi Barretina; Robert G Maki; Cristina R Antonescu; Samuel Singer; Marc Ladanyi
Journal:  Nat Rev Cancer       Date:  2011-07-14       Impact factor: 60.716

4.  Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.

Authors:  Joshua T Dilworth; Jonathan W Wojtkowiak; Patricia Mathieu; Michael A Tainsky; John J Reiners; Raymond R Mattingly; Chad N Hancock
Journal:  Cancer Biol Ther       Date:  2008-12-07       Impact factor: 4.742

5.  Mutational analysis of SOS1 gene in acute myeloid leukemia.

Authors:  Ryohei Tanizaki; Akira Katsumi; Hitoshi Kiyoi; Shinji Kunishima; Toshihiro Iwasaki; Yuichi Ishikawa; Miki Kobayashi; Akihiro Abe; Tadashi Matsushita; Takashi Watanabe; Tetsuhito Kojima; Kozo Kaibuchi; Seiji Kojima; Tomoki Naoe
Journal:  Int J Hematol       Date:  2008-10-30       Impact factor: 2.490

6.  Design of versatile biochemical switches that respond to amplitude, duration, and spatial cues.

Authors:  Azi Lipshtat; Gomathi Jayaraman; John Cijiang He; Ravi Iyengar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

7.  Tissue-specific ablation of Prkar1a causes schwannomas by suppressing neurofibromatosis protein production.

Authors:  Georgette N Jones; Chhavy Tep; William H Towns; Georgeta Mihai; Ian D Tonks; Graham F Kay; Petra M Schmalbrock; Anat O Stemmer-Rachamimov; Sung Ok Yoon; Lawrence S Kirschner
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

8.  Congenital (infantile) pseudarthrosis of the fibula associated with osteofibrous dysplasia.

Authors:  Masanori Hisaoka; Hiroshi Hashimoto; Takayuki Ohguri; Takatoshi Aoki; Sumika Okamoto; Hidetoshi Tanaka; Nobukazu Okimoto; Toshitaka Nakamura; Tsuyoshi Ishida
Journal:  Skeletal Radiol       Date:  2004-07-16       Impact factor: 2.199

9.  Hypoxia-Associated Factor (HAF) Mediates Neurofibromin Ubiquitination and Degradation Leading to Ras-ERK Pathway Activation in Hypoxia.

Authors:  Yangsook Song Green; Timothy Sargis; Ethan Conrad Reichert; Eleanor Rudasi; Daniel Fuja; Eric Jonasch; Mei Yee Koh
Journal:  Mol Cancer Res       Date:  2019-01-31       Impact factor: 5.852

10.  The 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment.

Authors:  Jan Zietsch; Nicolas Ziegenhagen; Frank L Heppner; David Reuss; Andreas von Deimling; Nikola Holtkamp
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.